Cardiol Therapeutics (CRDL) Stock Chart & Stock Price History C$1.91 -0.15 (-7.28%) As of 08/1/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesInsider TradesBuy This Stock Cardiol Therapeutics Stock Price Performance The Cardiol Therapeutics (CRDL) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 30.04%, with a year-to-date return of 3.24%. In the past month, the stock has decreased 6.83%, reflecting recent market activity. As of the latest close, Cardiol Therapeutics traded at C$1.91 with a market cap of C$158.49 million and volume of 143,893 shares. Receive CRDL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cardiol Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-7.28%1 Month Performance-6.83%3 Month Performance+20.13%Year-To-Date Performance+3.24%1 Year Performance-30.04% CRDL Stock Chart for Tuesday, August, 5, 2025 CRDL Chart by TradingView Cardiol Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/04/2025C$1.91C$1.91C$2.05C$1.90143,893 shsC$158.49 million08/01/2025C$2.06C$1.91-7.28%C$2.05C$1.90143,893 shsC$158.49 million07/31/2025C$2.08C$2.06-0.96%C$2.15C$2.02124,003 shsC$170.94 million07/30/2025C$2.01C$2.08+3.48%C$2.13C$1.98134,230 shsC$172.60 million07/29/2025C$2.10C$2.01-4.29%C$2.14C$1.97142,863 shsC$166.79 million07/28/2025C$1.96C$2.10+7.14%C$2.17C$1.98267,396 shsC$174.26 million07/25/2025C$1.92C$1.96+2.08%C$1.97C$1.8783,203 shsC$162.64 million07/24/2025C$1.95C$1.92-1.54%C$1.97C$1.8977,134 shsC$159.32 million07/23/2025C$1.88C$1.95+3.72%C$1.95C$1.80106,253 shsC$161.81 million07/22/2025C$1.67C$1.88+12.57%C$1.96C$1.69289,801 shsC$156 million Get the Latest News and Ratings for CRDL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cardiol Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/21/2025C$1.61C$1.67+3.73%C$1.69C$1.60133,934 shsC$138.57 million07/18/2025C$1.61C$1.61C$1.62C$1.56113,897 shsC$133.60 million07/17/2025C$1.76C$1.61-8.52%C$1.78C$1.61202,172 shsC$133.60 million07/16/2025C$1.74C$1.76+1.15%C$1.80C$1.7291,920 shsC$146.04 million07/15/2025C$1.81C$1.74-3.87%C$1.84C$1.74132,300 shsC$144.38 million07/14/2025C$1.80C$1.81+0.56%C$1.87C$1.78129,972 shsC$150.19 million07/11/2025C$1.86C$1.80-3.23%C$1.87C$1.7668,784 shsC$149.36 million07/10/2025C$1.88C$1.86-1.06%C$1.91C$1.8074,450 shsC$154.34 million07/09/2025C$1.90C$1.88-1.05%C$1.91C$1.8549,950 shsC$156 million07/08/2025C$1.97C$1.90-3.55%C$1.99C$1.86115,520 shsC$157.66 million07/07/2025C$2.07C$1.97-4.83%C$2.08C$1.94109,567 shsC$163.47 million07/04/2025C$2.05C$2.07+0.98%C$2.08C$2.0177,015 shsC$171.77 million Related Companies Tilray Brands Stock Price Chart Aimia Stock Price Chart Fennec Pharmaceuticals Stock Price Chart International Tower Hill Mines Stock Price Chart Gear Energy Stock Price Chart Graphite One Stock Price Chart EQ Stock Price Chart Medicenna Therapeutics Stock Price Chart Canadian Gold Stock Price Chart CI Canadian Convertible Bond ETF Common Stock Price Chart Receive CRDL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cardiol Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (TSE:CRDL) was last updated on 8/5/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredEx-Hedge Fund Manager Uncovers $100 Trillion Land ShiftTrump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to u...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardiol Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardiol Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
